期刊全稱(chēng) | Acute Myelogenous Leukemia | 期刊簡(jiǎn)稱(chēng) | Genetics, Biology an | 影響因子2023 | Lalitha Nagarajan | 視頻video | http://file.papertrans.cn/145/144395/144395.mp4 | 發(fā)行地址 | Contains chapters from pioneers in the area of genetic mechanisms, targeted therapy, biology and mouse models for acute myelogenous leukemia.Includes supplementary material: | 學(xué)科分類(lèi) | Cancer Treatment and Research | 圖書(shū)封面 |  | 影響因子 | .Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as the population ages. Over the past 15 years, genetic mechanisms underlying AML have begun to unfold. Additional research in this area has helped identify key components and characteristics. Consequently, targeted therapy of AML is receiving much attention. It is the hope of researchers that as with chronic myelogenous leukemia (CML), and the drug, Gleevec, a targeted therapy for AML will be discovered. . | Pindex | Book 2010 |
The information of publication is updating
|
|